JMIR Cardio最新文献

筛选
英文 中文
Optimization of the Care4Today Digital Health Platform to Enhance Self-Reporting of Medication Adherence and Health Experiences in Patients With Coronary or Peripheral Artery Disease: Mixed Methods Study.
JMIR Cardio Pub Date : 2025-03-17 DOI: 10.2196/56053
Stephanie Juan, Ante Harxhi, Simrati Kaul, Breeana Woods, Monica Tran, Gabrielle Geonnotti, Archit Gupta, Emily Dean, Cassandra E Saunders, Gloria Payne
{"title":"Optimization of the Care4Today Digital Health Platform to Enhance Self-Reporting of Medication Adherence and Health Experiences in Patients With Coronary or Peripheral Artery Disease: Mixed Methods Study.","authors":"Stephanie Juan, Ante Harxhi, Simrati Kaul, Breeana Woods, Monica Tran, Gabrielle Geonnotti, Archit Gupta, Emily Dean, Cassandra E Saunders, Gloria Payne","doi":"10.2196/56053","DOIUrl":"https://doi.org/10.2196/56053","url":null,"abstract":"<p><strong>Background: </strong>Care4Today is a digital health platform developed by Johnson & Johnson comprising a patient mobile app (Care4Today Connect), a health care provider (HCP) portal, and an educational website. It aims to improve medication adherence; enable self-reporting of health experiences; provide patient education; enhance connection with HCPs; and facilitate data and analytics learning across disease areas, including cardiovascular disease.</p><p><strong>Objective: </strong>This study aimed to gather patient feedback on Care4Today Connect, specifically the coronary artery disease (CAD) and peripheral artery disease (PAD) module, and to cocreate and validate features with patients to optimize the app experience for those with CAD, PAD, or both.</p><p><strong>Methods: </strong>We conducted 3 research engagements between November 2022 and May 2023. Participants were US-based adults recruited and consented through the sponsor's Patient Engagement Research Council program. Participants self-reported a diagnosis of cardiovascular disease, and in some cases, specifically, CAD, PAD, or both. Part 1, internet survey, posed quantitative questions with Likert-scale answer options about existing app features. Part 2, virtual focus group, and part 3, virtual individual interviews, both used semistructured qualitative discussion to cocreate and validate new app enhancements. The quantitative data from part 1 was evaluated descriptively to categorize mobile health app use, confidence in the ability to use the app, and motivations for app use. The qualitative discussions from parts 2 and 3 were synthesized to understand participants' app needs and preferences to inform an optimal app experience.</p><p><strong>Results: </strong>The response rate for part 1, internet survey, was 67% (37/55). Most participants felt at least somewhat confident using the app after seeing the newly added app tutorial (33/37, 89%), and at least somewhat confident in their ability to earn points for completing activities using app instructions (33/37, 89%). In part 2, virtual focus group (n=3), and part 3, virtual individual interviews (n=8), participants collectively preferred to enhance the app with (1) the ability to automatically add medication data for tracking and (2) the ability to receive relevant care team feedback on their self-reported health experiences. Participants would be willing to spend 10-15 minutes a day tracking 4-5 health experiences, especially those requested by their HCP.</p><p><strong>Conclusions: </strong>Participants prefer apps that can reduce user burden and provide information relevant to them. Care4Today Connect can optimize the user experience for patients with CAD, PAD, or both with the automatic addition of medication data for tracking and in-app care team feedback on patient self-reported health experiences.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"9 ","pages":"e56053"},"PeriodicalIF":0.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143648667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Stakeholder Perspectives on the Barriers and Facilitators of Implementing Digital Technologies for Heart Disease Diagnosis: Qualitative Study.
JMIR Cardio Pub Date : 2025-03-05 DOI: 10.2196/66464
Kamilla Abdullayev, Tim J A Chico, Jiana Canson, Matthew Mantelow, Oli Buckley, Joan Condell, Richard J Van Arkel, Vanessa Diaz-Zuccarini, Faith Matcham
{"title":"Exploring Stakeholder Perspectives on the Barriers and Facilitators of Implementing Digital Technologies for Heart Disease Diagnosis: Qualitative Study.","authors":"Kamilla Abdullayev, Tim J A Chico, Jiana Canson, Matthew Mantelow, Oli Buckley, Joan Condell, Richard J Van Arkel, Vanessa Diaz-Zuccarini, Faith Matcham","doi":"10.2196/66464","DOIUrl":"10.2196/66464","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Digital technologies are increasingly being implemented in health care to improve the quality and efficiency of care for patients. However, the rapid adoption of health technologies over the last 5 years has failed to adequately consider patient and clinician needs, which results in ineffective implementation. There is also a lack of consideration for the differences between patient and clinician needs, resulting in overgeneralized approaches to the implementation and use of digital health technologies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aimed to explore barriers and facilitators of the implementation of digital technologies in the diagnosis of heart disease for both patients and clinicians, and to provide recommendations to increase the acceptability of novel health technologies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We recruited 32 participants from across the United Kingdom, including 23 (72%) individuals with lived experience of heart disease and 9 (28%) clinicians involved in diagnosing heart disease. Participants with experience of living with heart disease took part in semistructured focused groups, while clinicians contributed to one-to-one semistructured interviews. Inductive thematic analysis using a phenomenological approach was conducted to analyze the resulting qualitative data and to identify themes. Results were discussed with a cardiovascular patient advisory group to enhance the rigor of our interpretation of the data.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Emerging themes were separated into facilitators and barriers and categorized into resource-, technology-, and user-related themes. Resource-related barriers and facilitators related to concerns around increased clinician workload, the high cost of digital technologies, and systemic limitations within health care systems such as outdated equipment and limited support. Technology-related barriers and facilitators included themes related to reliability, accuracy, safety parameters, data security, ease of use, and personalization, all of which can impact engagement and trust with digital technologies. Finally, the most prominent themes were the user-related barriers and facilitators, which encompassed user attitudes, individual-level variation in preferences and capabilities, and impact on quality of health care experiences. This theme captured a wide variety of perspectives among the sample and revealed how patient and clinician attitudes and personal experiences substantially impact engagement with digital health technologies across the cardiovascular care pathway.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Our findings highlight the importance of considering both patient and clinician needs and preferences when investigating the barriers and facilitators to effective implementation of digital health technologies. Facilitators to technology adoption include the need for cost-effective, accurate, reliable, and easy-to-use systems as well as adequate setup s","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"9 ","pages":"e66464"},"PeriodicalIF":0.0,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143575794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Atrial Fibrillation Relapse Using Bayesian Networks: Explainable AI Approach.
JMIR Cardio Pub Date : 2025-02-11 DOI: 10.2196/59380
João Miguel Alves, Daniel Matos, Tiago Martins, Diogo Cavaco, Pedro Carmo, Pedro Galvão, Francisco Moscoso Costa, Francisco Morgado, António Miguel Ferreira, Pedro Freitas, Cláudia Camila Dias, Pedro Pereira Rodrigues, Pedro Adragão
{"title":"Predicting Atrial Fibrillation Relapse Using Bayesian Networks: Explainable AI Approach.","authors":"João Miguel Alves, Daniel Matos, Tiago Martins, Diogo Cavaco, Pedro Carmo, Pedro Galvão, Francisco Moscoso Costa, Francisco Morgado, António Miguel Ferreira, Pedro Freitas, Cláudia Camila Dias, Pedro Pereira Rodrigues, Pedro Adragão","doi":"10.2196/59380","DOIUrl":"10.2196/59380","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Atrial fibrillation (AF) is a prevalent arrhythmia associated with significant morbidity and mortality. Despite advancements in ablation techniques, predicting recurrence of AF remains a challenge, necessitating reliable models to identify patients at risk of relapse. Traditional scoring systems often lack applicability in diverse clinical settings and may not incorporate the latest evidence-based factors influencing AF outcomes. This study aims to develop an explainable artificial intelligence model using Bayesian networks to predict AF relapse postablation, leveraging on easily obtainable clinical variables.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aims to investigate the effectiveness of Bayesian networks as a predictive tool for AF relapse following a percutaneous pulmonary vein isolation (PVI) procedure. The objectives include evaluating the model's performance using various clinical predictors, assessing its adaptability to incorporate new risk factors, and determining its potential to enhance clinical decision-making in the management of AF.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This study analyzed data from 480 patients with symptomatic drug-refractory AF who underwent percutaneous PVI. To predict AF relapse following the procedure, an explainable artificial intelligence model based on Bayesian networks was developed. The model used a variable number of clinical predictors, including age, sex, smoking status, preablation AF type, left atrial volume, epicardial fat, obstructive sleep apnea, and BMI. The predictive performance of the model was evaluated using the area under the receiver operating characteristic curve (AUC-ROC) metrics across different configurations of predictors (5, 6, and 7 variables). Validation was conducted through four distinct sampling techniques to ensure robustness and reliability of the predictions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The Bayesian network model demonstrated promising predictive performance for AF relapse. Using 5 predictors (age, sex, smoking, preablation AF type, and obstructive sleep apnea), the model achieved an AUC-ROC of 0.661 (95% CI 0.603-0.718). Incorporating additional predictors improved performance, with a 6-predictor model (adding BMI) achieving an AUC-ROC of 0.703 (95% CI 0.652-0.753) and a 7-predictor model (adding left atrial volume and epicardial fat) achieving an AUC-ROC of 0.752 (95% CI 0.701-0.800). These results indicate that the model can effectively estimate the risk of AF relapse using readily available clinical variables. Notably, the model maintained acceptable diagnostic accuracy even in scenarios where some predictive features were missing, highlighting its adaptability and potential use in real-world clinical settings.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The developed Bayesian network model provides a reliable and interpretable tool for predicting AF relapse in patients undergoing percutaneous PVI. By using easily accessible clinical variables,","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"9 ","pages":"e59380"},"PeriodicalIF":0.0,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11835785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143399022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wearable Electrocardiogram Technology: Help or Hindrance to the Modern Doctor?
JMIR Cardio Pub Date : 2025-02-10 DOI: 10.2196/62719
Samuel Smith, Shalisa Maisrikrod
{"title":"Wearable Electrocardiogram Technology: Help or Hindrance to the Modern Doctor?","authors":"Samuel Smith, Shalisa Maisrikrod","doi":"10.2196/62719","DOIUrl":"10.2196/62719","url":null,"abstract":"<p><strong>Unlabelled: </strong>Electrocardiography is an essential tool in the arsenal of medical professionals, Traditionally, patients have been required to meet health care practitioners in person to have an electrocardiogram (ECG) recorded and interpreted. This may result in paroxysmal arrhythmias being missed, as well as decreased patient convenience, and thus reduced uptake. The advent of wearable ECG devices built into consumer smartwatches has allowed unparalleled access to ECG monitoring for patients. Not only are these modern devices more portable than traditional Holter monitors, but with the addition of artificial intelligence (AI)-led rhythm interpretation, diagnostic accuracy is improved greatly when compared with conventional ECG-machine interpretation. The improved wearability may also translate into increased rates of detected arrhythmias. Despite the many positives, wearable ECG technology brings with it its own challenges. Diagnostic accuracy, managing patient expectations and limitations, and incorporating home ECG monitoring into clinical guidelines have all arisen as challenges for the modern clinician. Decentralized monitoring and patient alerts to supposed arrhythmias have the potential to increase patient anxiety and health care visitations (and therefore costs). To better obtain meaningful data from these devices, provide optimal patient care, and provide meaningful explanations to patients, providers need to understand the basic sciences underpinning these devices, how these relate to the surface ECG, and the implications in diagnostic accuracy. This review article examines the underlying physiological principles of electrocardiography, as well as examines how wearable ECGs have changed the clinical landscape today, where their limitations lie, and what clinicians can expect in the future with their increasing use.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"9 ","pages":"e62719"},"PeriodicalIF":0.0,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11833192/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technology Readiness Level and Self-Reported Health in Recipients of an Implantable Cardioverter Defibrillator: Cross-Sectional Study.
JMIR Cardio Pub Date : 2025-02-06 DOI: 10.2196/58219
Natasha Rosenmeier, David Busk, Camilla Dichman, Kim Mechta Nielsen, Lars Kayser, Mette Kirstine Wagner
{"title":"Technology Readiness Level and Self-Reported Health in Recipients of an Implantable Cardioverter Defibrillator: Cross-Sectional Study.","authors":"Natasha Rosenmeier, David Busk, Camilla Dichman, Kim Mechta Nielsen, Lars Kayser, Mette Kirstine Wagner","doi":"10.2196/58219","DOIUrl":"10.2196/58219","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Approximately 200,000 implantable cardioverter defibrillators (ICDs) are implanted annually worldwide, with around 20% of recipients experiencing significant psychological distress. Despite this, there are no ICD guidelines addressing mental health as part of rehabilitation programs, which primarily focus on educating patients about their condition and prognosis. There is a need to include elements such as emotional distress, social interactions, and the future use of technologies like apps and virtual communication in ICD rehabilitation, without increasing the burden on health care professionals.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aimed to demonstrate how data from the Readiness for Health Technology Index (READHY), combined with sociodemographic characteristics and exploratory interviews, can be used to construct profiles of recipients of an ICD, describing their ability to manage their condition, their need for support, and their digital health literacy. This aims to enhance health care professionals' understanding of different patient archetypes, serving as guidance in delivering personalized services tailored to the needs, resources, and capabilities of individual recipients of ICDs.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Overall, 79 recipients of an ICD participated in a survey assessing technology readiness using the READHY. The survey also collected sociodemographic data such as age, sex, and educational level. Self-reported health was measured using a Likert scale. Cluster analysis categorized participants into profiles based on their READHY scores. Correlations between READHY scores and self-reported health were examined. In addition, qualitative interviews with representatives from different readiness profiles provided deeper insights.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Four technology readiness profiles were found: (1) profile 1 (low digital health literacy, insufficient on 5 dimensions), (2) profile 2 (sufficient on all dimensions), (3) profile 3 (consistently sufficient readiness on all dimensions), and (4) profile 4 (insufficient readiness on 9 dimensions). Participants in profile 4, characterized by the lowest readiness levels, were significantly younger (P=.03) and had lower self-reported health (P&lt;.001) than those in profile 3. A correlation analysis revealed that higher READHY scores were associated with better self-reported health across all dimensions. Qualitative interviews highlighted differences in self-management approaches and the experience of support between profiles, emphasizing the essential role of social support toward the rehabilitation journeys of recipients of an ICD. Two patient vignettes were created based on the characteristics from the highest and lowest profiles.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Using the READHY instrument to create patient profiles demonstrates how it can be used to make health care professionals aware of specific needs within the group of recipients of a","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"9 ","pages":"e58219"},"PeriodicalIF":0.0,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11843055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causal Inference for Hypertension Prediction With Wearable E lectrocardiogram and P hotoplethysmogram Signals: Feasibility Study.
JMIR Cardio Pub Date : 2025-01-23 DOI: 10.2196/60238
Ke Gon G, Yifan Chen, Xinyue Song, Zhizhong Fu, Xiaorong Ding
{"title":"Causal Inference for Hypertension Prediction With Wearable E lectrocardiogram and P hotoplethysmogram Signals: Feasibility Study.","authors":"Ke Gon G, Yifan Chen, Xinyue Song, Zhizhong Fu, Xiaorong Ding","doi":"10.2196/60238","DOIUrl":"10.2196/60238","url":null,"abstract":"<p><strong>Background: </strong>Hypertension is a leading cause of cardiovascular disease and premature death worldwide, and it puts a heavy burden on the healthcare system. Therefore, it is very important to detect and evaluate hypertension and related cardiovascular events to enable early prevention, detection, and management. Hypertension can be detected in a timely manner with cardiac signals, such as through an electrocardiogram (ECG) and photoplethysmogram (PPG) , which can be observed via wearable sensors. Most previous studies predicted hypertension from ECG and PPG signals with extracted features that are correlated with hypertension. However, correlation is sometimes unreliable and may be affected by confounding factors .</p><p><strong>Objective: </strong>The aim of this study was to investigate the feasibility of predicting the risk of hypertension by exploring features that are causally related to hypertension via causal inference methods. Additionally, we paid special attention to and verified the reliability and effectiveness of causality compared to correlation.</p><p><strong>Methods: </strong>We used a large public dataset from the Aurora Project , which was conducted by Microsoft Research. The dataset included diverse individuals who were balanced in terms of gender, age, and the condition of hypertension, with their ECG and PPG signals simultaneously acquired with wrist -worn wearable devices. We first extracted 205 features from the ECG and PPG signals, calculated 6 statistical metrics for these 205 features, and selected some valuable features out of the 205 features under each statistical metric. Then, 6 causal graphs of the selected features for each kind of statistical metric and hypertension were constructed with the equivalent greedy search algorithm. We further fused the 6 causal graphs into 1 causal graph and identified features that were causally related to hypertension from the causal graph . Finally, we used these features to detect hypertension via machine learning algorithms.</p><p><strong>Results: </strong>We validated the proposed method on 405 subjects. We identified 24 causal features that were associated with hypertension. The causal features could detect hypertension with an accuracy of 89%, precision of 92 % , and recall of 82%, which outperformed detection with correlation features (accuracy of 85%, precision of 88 % , and recall of 77%).</p><p><strong>Conclusions: </strong>The results indicated that the causal inference -based approach can potentially clarify the mechanism of hypertension detection with noninvasive signals and effectively detect hypertension. It also reveal ed that causality can be more reliable and effective than correlation for hypertension detection and other application scenarios.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"9 ","pages":"e60238"},"PeriodicalIF":0.0,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11811217/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143046919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Medication Management App (Smart-Meds) for Patients After an Acute Coronary Syndrome: Pilot Pre-Post Mixed Methods Study. 针对急性冠状动脉综合征患者的药物管理应用(Smart-Meds):前-后混合方法试点研究。
JMIR Cardio Pub Date : 2025-01-23 DOI: 10.2196/50693
Frederic Ehrler, Liliane Gschwind, Hamdi Hagberg, Philippe Meyer, Katherine Blondon
{"title":"A Medication Management App (Smart-Meds) for Patients After an Acute Coronary Syndrome: Pilot Pre-Post Mixed Methods Study.","authors":"Frederic Ehrler, Liliane Gschwind, Hamdi Hagberg, Philippe Meyer, Katherine Blondon","doi":"10.2196/50693","DOIUrl":"10.2196/50693","url":null,"abstract":"<p><strong>Background: </strong>Medication nonadherence remains a significant challenge in the management of chronic conditions, often leading to suboptimal treatment outcomes and increased health care costs. Innovative interventions that address the underlying factors contributing to nonadherence are needed. Gamified mobile apps have shown promise in promoting behavior change and engagement.</p><p><strong>Objective: </strong>This pilot study aimed to evaluate the efficacy and usability of a gamified mobile app that used a narrative storytelling approach to enhance medication adherence among patients following acute coronary syndrome (ACS). The study aimed to assess changes in participants' beliefs about medication and self-reported adherence before and after the intervention. Additionally, user feedback regarding the narrative component of the app was gathered.</p><p><strong>Methods: </strong>Overall, 18 patients who recently experienced ACS were recruited for a 1-month intervention using the gamified app. Participants' beliefs about medication and self-reported adherence were assessed using standardized scales pre- and postintervention. The app's usability was also evaluated through a postintervention questionnaire. Statistical analyses were performed to determine the significance of changes in belief and adherence scores.</p><p><strong>Results: </strong>Although 33% (6/18) of the participants did not use the intervention more than once, the remaining 12 remained engaged during the 30 days of the study. The results did not indicate a significant improvement in participants' beliefs about medication following the intervention. However, self-reported adherence significantly improved (P<.05) after the intervention with a mean score going from 29.1 (SD 6.9) to 32.4 (SD 5.6), with participants demonstrating a greater self-efficacy to their prescribed medication regimen. However, the results did not indicate a significant improvement in participants' beliefs about medication. With a mean average score of 80.6, the usability evaluation indicates a good usability rating for the gamified app. However, the narrative storytelling component of the app was not favored by the participants, as indicated by their feedback.</p><p><strong>Conclusions: </strong>This pilot study suggests that a gamified mobile app using narration may effectively enhance medication self-efficacy and positively influence patients' beliefs about medication following ACS. However, the narrative component of the app did not receive favorable feedback from participants. Future research should focus on exploring alternative methods to engage participants in the app's narrative elements while maintaining the positive impact on adherence and beliefs about medication observed in this study.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"9 ","pages":"e50693"},"PeriodicalIF":0.0,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781755/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143046915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimating Trends in Cardiovascular Disease Risk for the EXPOSE (Explaining Population Trends in Cardiovascular Risk: A Comparative Analysis of Health Transitions in South Africa and England) Study: Repeated Cross-Sectional Study. 估计暴露人群心血管疾病风险的趋势(解释心血管风险的人口趋势:南非和英国健康转变的比较分析)研究:重复横断面研究。
JMIR Cardio Pub Date : 2025-01-20 DOI: 10.2196/64893
Shaun Scholes, Jennifer S Mindell, Mari Toomse-Smith, Annibale Cois, Kafui Adjaye-Gbewonyo
{"title":"Estimating Trends in Cardiovascular Disease Risk for the EXPOSE (Explaining Population Trends in Cardiovascular Risk: A Comparative Analysis of Health Transitions in South Africa and England) Study: Repeated Cross-Sectional Study.","authors":"Shaun Scholes, Jennifer S Mindell, Mari Toomse-Smith, Annibale Cois, Kafui Adjaye-Gbewonyo","doi":"10.2196/64893","DOIUrl":"10.2196/64893","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Cardiovascular diseases (CVDs) are the leading cause of death globally. Demographic, behavioral, socioeconomic, health care, and psychosocial variables considered risk factors for CVD are routinely measured in population health surveys, providing opportunities to examine health transitions. Studying the drivers of health transitions in countries where multiple burdens of disease persist (eg, South Africa), compared with countries regarded as models of \"epidemiologic transition\" (eg, England), can provide knowledge on where best to intervene and direct resources to reduce the disease burden.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The EXPOSE (Explaining Population Trends in Cardiovascular Risk: A Comparative Analysis of Health Transitions in South Africa and England) study analyzes microlevel data collected from multiple nationally representative population health surveys conducted in these 2 countries between 1998 and 2017. Creating a harmonized dataset by pooling repeated cross-sectional surveys to model trends in CVD risk is challenging due to changes in aspects such as survey content, question wording, inclusion of boost samples, weighting, measuring equipment, and guidelines for data protection. This study aimed to create a harmonized dataset based on the annual Health Surveys for England to estimate trends in mean predicted 10-year CVD risk (primary outcome) and its individual risk components (secondary outcome).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We compiled a harmonized dataset to estimate trends between 1998 and 2017 in the English adult population, including the primary and secondary outcomes, and potential drivers of those trends. Laboratory- and non-laboratory-based World Health Organization (WHO) and Globorisk algorithms were used to calculate the predicted 10-year total (fatal and nonfatal) CVD risk. Sex-specific estimates of the mean 10-year CVD risk and its components by survey year were calculated, accounting for the complex survey design.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Laboratory- and non-laboratory-based 10-year CVD risk scores were calculated for 33,628 and 61,629 participants aged 40 to 74 years, respectively. The absolute predicted 10-year risk of CVD declined significantly on average over the last 2 decades in both sexes (for linear trend; all P&lt;.001). In men, the mean of the laboratory-based WHO risk score was 10.1% (SE 0.2%) and 8.4% (SE 0.2%) in 1998 and 2017, respectively; corresponding figures in women were 5.6% (SE 0.1%) and 4.5% (SE 0.1%). In men, the mean of the non-laboratory-based WHO risk score was 9.6% (SE 0.1%) and 8.9% (SE 0.2%) in 1998 and 2017, respectively; corresponding figures in women were 5.8% (SE 0.1%) and 4.8% (SE 0.1%). Predicted CVD risk using the Globorisk algorithms was lower on average in absolute terms, but the pattern of change was very similar. Trends in the individual risk components showed a complex pattern.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Harmonized data from repe","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"9 ","pages":"e64893"},"PeriodicalIF":0.0,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11791442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143005583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Unsupervised YouTube Dance Exercise for Patients With Hypertension: Randomized Controlled Trial. 无监督YouTube舞蹈运动对高血压患者的疗效:随机对照试验。
JMIR Cardio Pub Date : 2025-01-09 DOI: 10.2196/65981
Mizuki Sakairi, Taiju Miyagami, Hiroki Tabata, Naotake Yanagisawa, Mizue Saita, Mai Suzuki, Kazutoshi Fujibayashi, Hiroshi Fukuda, Toshio Naito
{"title":"Efficacy of Unsupervised YouTube Dance Exercise for Patients With Hypertension: Randomized Controlled Trial.","authors":"Mizuki Sakairi, Taiju Miyagami, Hiroki Tabata, Naotake Yanagisawa, Mizue Saita, Mai Suzuki, Kazutoshi Fujibayashi, Hiroshi Fukuda, Toshio Naito","doi":"10.2196/65981","DOIUrl":"10.2196/65981","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;High blood pressure (BP) is linked to unhealthy lifestyles, and its treatment includes medications and exercise therapy. Many previous studies have evaluated the effects of exercise on BP improvement; however, exercise requires securing a location, time, and staff, which can be challenging in clinical settings. The antihypertensive effects of dance exercise for patients with hypertension have already been verified, and it has been found that adherence and dropout rates are better compared to other forms of exercise. If the burden of providing dance instruction is reduced, dance exercise will become a highly useful intervention for hypertension treatment.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aims to investigate the effects of regular exercise therapy using dance videos on the BP of patients with hypertension, with the goal of providing a reference for prescribing exercise therapy that is highly feasible in clinical settings.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This nonblind, double-arm, randomized controlled trial was conducted at Juntendo University, Tokyo, from April to December 2023. A total of 40 patients with hypertension were randomly assigned to either an intervention group (dance) or a control group (self-selected exercise), with each group comprising 20 participants. The intervention group performed daily dance exercises using street dance videos (10 min per video) uploaded to YouTube. The control group was instructed to choose any exercise other than dance and perform it for 10 minutes each day. The activity levels of the participants were monitored using a triaxial accelerometer. BP and body composition were measured on the day of participation and after 2 months. During the intervention period, we did not provide exercise instruction or supervise participants' activities.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 34 patients were included in the study (16 in the intervention group and 18 in the control group). The exclusion criteria were the absence of BP data, medication changes, or withdrawal from the study. The mean age was 56 (SD 9.8) years, and 18 (53%) of the patients were female. The mean BMI was 28.0 (SD 6.3) m/kg&lt;sup&gt;2&lt;/sup&gt;, and systolic blood pressure (SBP) and diastolic blood pressure (DBP) were 139.5 (SD 17.1) mm Hg and 85.8 (SD 9.1) mm Hg, respectively. The basic characteristics did not differ between the two groups. In the multivariate analysis, SBP and DBP improved significantly in the intervention group compared to the control group (mean SBP -12.8, SD 6.1 mm Hg; P=.047; mean DBP -9.7, SD 3.3 mm Hg; P=.006).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This study evaluated the effects of dance exercise on patients with hypertension, as previously verified, under the additional condition of using dance videos without direct staff instruction or supervision. The results showed that dance videos were more effective in lowering BP than conventional exercise prescriptions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Trial reg","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"9 ","pages":"e65981"},"PeriodicalIF":0.0,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11757983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142949147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Dragonnet and Conformal Inference for Estimating Individualized Treatment Effects for Personalized Stroke Prevention: Retrospective Cohort Study. 应用Dragonnet和适形推理评估个体化治疗对个体化脑卒中预防的效果:回顾性队列研究。
JMIR Cardio Pub Date : 2025-01-08 DOI: 10.2196/50627
Sermkiat Lolak, John Attia, Gareth J McKay, Ammarin Thakkinstian
{"title":"Application of Dragonnet and Conformal Inference for Estimating Individualized Treatment Effects for Personalized Stroke Prevention: Retrospective Cohort Study.","authors":"Sermkiat Lolak, John Attia, Gareth J McKay, Ammarin Thakkinstian","doi":"10.2196/50627","DOIUrl":"10.2196/50627","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Stroke is a major cause of death and disability worldwide. Identifying individuals who would benefit most from preventative interventions, such as antiplatelet therapy, is critical for personalized stroke prevention. However, traditional methods for estimating treatment effects often focus on the average effect across a population and do not account for individual variations in risk and treatment response.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aimed to estimate the individualized treatment effects (ITEs) for stroke prevention using a novel combination of Dragonnet, a causal neural network, and conformal inference. The study also aimed to determine and validate the causal effects of known stroke risk factors-hypertension (HT), diabetes mellitus (DM), dyslipidemia (DLP), and atrial fibrillation (AF)-using both a conventional causal model and machine learning models.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective cohort study was conducted using data from 275,247 high-risk patients treated at Ramathibodi Hospital, Thailand, between 2010 and 2020. Patients aged &gt;18 years with HT, DM, DLP, or AF were eligible. The main outcome was ischemic or hemorrhagic stroke, identified using International Classification of Diseases, 10th Revision (ICD-10) codes. Causal effects of the risk factors were estimated using a range of methods, including: (1) propensity score-based methods, such as stratified propensity scores, inverse probability weighting, and doubly robust estimation; (2) structural causal models; (3) double machine learning; and (4) Dragonnet, a causal neural network, which was used together with weighted split-conformal quantile regression to estimate ITEs.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;AF, HT, and DM were identified as significant stroke risk factors. Average causal risk effect estimates for these risk factors ranged from 0.075 to 0.097 for AF, 0.017 to 0.025 for HT, and 0.006 to 0.010 for DM, depending on the method used. Dragonnet yielded causal risk ratios of 4.56 for AF, 2.44 for HT, and 1.41 for DM, which is comparable to other causal models and the standard epidemiological case-control study. Mean ITE analysis indicated that several patients with DM or DM with HT, who were not receiving antiplatelet treatment at the time of data collection, showed reductions in total risk of -0.015 and -0.016, respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This study provides a comprehensive evaluation of stroke risk factors and demonstrates the feasibility of using Dragonnet and conformal inference to estimate ITEs of antiplatelet therapy for stroke prevention. The mean ITE analysis suggested that those with DM or DM with HT, who were not receiving antiplatelet treatment at the time of data collection, could potentially benefit from this therapy. The findings highlight the potential of these advanced techniques to inform personalized treatment strategies for stroke, enabling clinicians to identify individuals who a","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"9 ","pages":"e50627"},"PeriodicalIF":0.0,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11735012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142949144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信